Timothy P Walbert Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Timothy P Walbert is Chairman, President and CEO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Feb 25, 2022, when has been sold 25,000 shares (Ordinary Shares) at a price of $92.51 per share, resulting in proceeds of $2,312,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Timothy P Walbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2022	SELL Open market or private sale	$2,312,750 $92.51 p/Share	25,000 Reduced 4.09%	585,549 Ordinary Shares
Feb 25 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 3.93%	610,549 Ordinary Shares
Feb 11 2022	SELL Open market or private sale	$2,438,250 $97.53 p/Share	25,000 Reduced 4.09%	585,549 Ordinary Shares
Feb 11 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 3.93%	610,549 Ordinary Shares
Jan 31 2022	SELL Open market or private sale	$9,177,000 $91.77 p/Share	100,000 Reduced 14.59%	585,549 Ordinary Shares
Jan 28 2022	SELL Open market or private sale	$2,250,000 $90.0 p/Share	25,000 Reduced 3.52%	685,549 Ordinary Shares
Jan 28 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 3.4%	710,549 Ordinary Shares
Jan 21 2022	SELL Payment of exercise price or tax liability	$778,558 $86.42 p/Share	9,009 Reduced 1.3%	685,549 Ordinary Shares
Jan 21 2022	BUY Exercise of conversion of derivative security	-	20,336 Added 2.84%	694,558 Ordinary Shares
Jan 14 2022	SELL Open market or private sale	$2,250,500 $90.02 p/Share	25,000 Reduced 3.58%	674,222 Ordinary Shares
Jan 14 2022	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 3.45%	699,222 Ordinary Shares
Jan 05 2022	SELL Payment of exercise price or tax liability	$17,812,426 $101.84 p/Share	174,906 Reduced 20.6%	674,222 Ordinary Shares
Jan 05 2022	BUY Exercise of conversion of derivative security	-	241,750 Added 25.77%	696,232 Ordinary Shares
Jan 05 2022	BUY Grant, award, or other acquisition	-	152,896 Added 15.26%	849,128 Ordinary Shares
Dec 31 2021	SELL Open market or private sale	$8,121,750 $108.29 p/Share	75,000 Reduced 14.16%	454,482 Ordinary Shares
Dec 31 2021	BUY Exercise of conversion of derivative security	$553,500 $22.14 p/Share	25,000 Added 4.51%	529,482 Ordinary Shares
Nov 30 2021	SELL Open market or private sale	$5,127,500 $102.55 p/Share	50,000 Reduced 9.02%	504,482 Ordinary Shares
Nov 01 2021	SELL Open market or private sale	$2,970,000 $118.8 p/Share	25,000 Reduced 4.31%	554,482 Ordinary Shares
Sep 30 2021	SELL Open market or private sale	$5,546,000 $110.92 p/Share	50,000 Reduced 7.94%	579,482 Ordinary Shares
Sep 17 2021	SELL Bona fide gift	-	218,241 Reduced 25.74%	629,482 Ordinary Shares
Aug 27 2021	BUY Exercise of conversion of derivative security	$164,611 $22.14 p/Share	7,435 Added 0.87%	847,723 Ordinary Shares
Jul 30 2021	SELL Open market or private sale	$2,552,750 $102.11 p/Share	25,000 Reduced 2.89%	840,288 Ordinary Shares
Jul 28 2021	SELL Payment of exercise price or tax liability	$1,581,780 $102.5 p/Share	15,432 Reduced 1.75%	865,288 Ordinary Shares
Jul 28 2021	BUY Grant, award, or other acquisition	-	34,833 Added 3.8%	880,720 Ordinary Shares
Jul 08 2021	SELL Bona fide gift	-	5,000 Reduced 0.59%	845,887 Ordinary Shares

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

IPSC

Century Therapeutics, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

SGMT

Sagimet Biosciences Inc.

Director

TPW